摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-氰基硫代甲酰苯胺 | 4955-82-2

中文名称
1-氰基硫代甲酰苯胺
中文别名
N-苯基氰基硫代甲酰胺;1-氰基硫代甲苯酰胺
英文名称
1-cyanothioformanilide
英文别名
cyanothioformanilide;N-phenylcyanothioformamide;N-Phenyl-cyanthioformamid;1-cyano-N-phenylmethanethioamide
1-氰基硫代甲酰苯胺化学式
CAS
4955-82-2
化学式
C8H6N2S
mdl
MFCD00012312
分子量
162.215
InChiKey
GWWTVLNRPMKCKS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    77-80 °C(lit.)
  • 沸点:
    258.0±23.0 °C(Predicted)
  • 密度:
    1.2154 (rough estimate)
  • 稳定性/保质期:

    避免与不相容的材料接触。

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    67.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R20/21/22,R36/37/38
  • 海关编码:
    2930909090
  • 储存条件:
    密封保存,应储存在阴凉干燥的仓库中。

SDS

SDS:579af3aa1d095973f7695bec43172a51
查看
Name: 1-Cyanothioformanilide 97% Material Safety Data Sheet
Synonym: None
CAS: 4955-82-2
Section 1 - Chemical Product MSDS Name:1-Cyanothioformanilide 97% Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
4955-82-2 1-Cyanothioformanilide 97% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 4955-82-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 77-80C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6N2S
Molecular Weight: 162.1154

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4955-82-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Cyanothioformanilide - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 4955-82-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 4955-82-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4955-82-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-氰基硫代甲酰苯胺二甲基亚砜 作用下, 反应 19.0h, 以94%的产率得到苯基氨基甲酰氰
    参考文献:
    名称:
    碘-DMSO 介导 N-芳基氰基硫代甲酰胺向 N-芳基氰基甲酰胺的转化和 2-氰基苯并噻唑的意外形成
    摘要:
    氰基甲酰胺作为组装关键中间体和生物活性分子的有用成分无处不在。开发一种有效且简单的方法来处理这个主题是一个挑战。在此,我们证明了 I 2 -DMSO 氧化系统在从N制备N-芳基氰基甲酰胺中的有效性。-芳基氰基硫代甲酰胺。该合成方法具有条件温和、底物范围广、反应效率高等特点。此外,这种方法提供了一个很好的入口,可以专门提供 2-氰基苯并噻唑,它们是获得新荧光素类似物的有用底物。所有新产品的结构均通过多核核磁共振光谱和高精度质谱分析进行了阐明。用单晶X射线衍射对(4-溴苯基)氨基甲酰氰、5,6-二甲氧基苯并[ d ]噻唑-2-甲腈、5-(苄氧基)苯并[ d ]恶唑进行晶体结构测定-2-甲腈,4,7-二甲氧基苯并[ d]噻唑-2-甲腈和(5-碘-2,4-二甲氧基苯基)氨基甲酰氰,一种具有机理意义的关键中间体。
    DOI:
    10.1039/d2ra00049k
  • 作为产物:
    参考文献:
    名称:
    Reissert, Chemische Berichte, 1904, vol. 37, p. 3730
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Studies on 4-Thiazolidinones: Scope of the Reactions of 3-Aryl-2-thioxo-1,3-thiazolidin-4-ones with Cyanide and Cyanate Ions
    作者:Mohamed T. Omar、Mohamed E. Shaban、Nadia K. El-Aasar、Khaled F. Saied
    DOI:10.1002/hlca.200890159
    日期:2008.8
    3-diones 6 along with each of the preceding products. Treatment of the respective (E,Z)-5-(2-aryl-2-oxoethylidene) analogues 3b and 3c with CN− gave 4b and 4c and 2-(arylcarbonyl)-2-methoxy-4-oxopentanedinitriles 7b and 7c, in addition to 3,6-bis[2-(4-chlorophenyl)-1-methoxy-2-oxoethylidene]-1,4-dithiane-2,5-dione 8c, which has been generated from 3c. Reactions of 3c or 3d with NCO− provided 5c or 5d,
    的治疗3-芳基-2-代-1,3-噻唑烷-4-酮1与CN -和NCO -实现的环切割提供[(cyanocarbonothioyl)基]苯4和arylisothiocyanates 5,分别。对5-(2-芳基-2-氧代乙基)衍生物2进行类似处理,得到2,4-双(2-芳基-2-氧代亚乙基)环丁烷-1,3-二酮6以及每种前述产物。相应(处理E,Z)-5-(2-芳基-2-氧代亚乙基)类似物图3b和3c中与CN - ,得到图4b和4c中除了3,6-双[2-(2-(4-氯苯基)-1-甲氧基-2-氧代亚乙基] -1,4-二噻吩基-)之外,还包括2-(芳基羰基)-2-甲氧基-4-氧戊二烯腈7b和7c。由3c生成的2,5-dione 8c。的反应3C或3D与NCO -提供图5c或5d的与,一起8C或8D为纯的异构体。在MeO产物7和8的形成中,溶剂(MeOH)参与了。这些产品的结构基于微观分析和光谱数据。给出了上述转换的合理化。
  • Synthesis, characterization, and derivatization of some novel types of fluorinated mono- and bis-imidazolidineiminothiones with antitumor, antiviral, antibacterial, and antifungal activities
    作者:Marwa A.M.Sh. El-Sharief、Ziad Moussa、Ahmed M.Sh. El-Sharief
    DOI:10.1016/j.jfluchem.2011.06.015
    日期:2011.9
    Aspergillus niger, and Aspergillus flavus). Whereas compound 6a exhibited the highest antibacterial activity against Gram positive and Gram negative bacteria, 13b displayed the strongest antifungal activity against all fungal strains, reaching as high as 30 mm. Finally, 15a,b,d were subjected to in vitro testing of antiviral activity against hepatitis A virus (HAV), human herpes simplex virus 1 (HSV1), and Coxsackie
    一系列38种新型咪唑烷亚酮(6a – g,10a – h,13a,b,15a – d和16a),5-代氧杂咪唑烷-2,4-二酮(7a – d,11a – e,14a,b,和16B),和双- imidazolidineiminothiones(17 - 20),在各种化芳族取代基ñ - (1)和ñ-(3)的制备产率为75-85%。由化的N-芳基代甲酰苯胺和取代的芳族异氰酸酯,以及化的芳族异氰酸酯化的和非化的芳族N-芳基代甲酰苯胺反应,合成咪唑烷亚酮。所选产物的随后解产生了相应的5-代氧杂咪唑烷-2,4-二酮。初步筛选了几种针对Ehrlich腹癌细胞(EAC)的化合物,结果表明6f和16a的活性最高(分别为90%和80%抑制)。进一步评估针对其他肿瘤细胞系的细胞毒性,得出IC 50值为0.67至3.83μg/ mL,其中化合物15a和16a对所有细胞
  • Reactions of Cyanothioformamide and Thiohydantoin Derivatives With Some Arylidenes of Cyanothioacetamide and Other Elecetrophilic and Nucleophilic Reagents
    作者:A. M. Sh. El-Sharief、F. F. Mahmoud、N. M. Taha、E. M. Ahmed
    DOI:10.1080/104265090517343
    日期:2005.2
    Abstract N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)cyanothioformamide was synthesized from the corresponding 4-amino-pyrazole. Various cyanothioformamides were reacted with different arylidenes of cyanothioacetamide to produce either 4-imino-5-thioxo-3-(pyrroline & pyrrolidine)carbonitrile or pyrrolo[3,2-d]thiazole. Interaction of thiohydantoin with the arylidenes of either malononitrile
    摘要 以相应的4-基-吡唑为原料合成了N-(1,5-二甲基-3-氧代-2-苯基-2,3-二氢-1H-吡唑-4-基)代甲酰胺。各种代甲酰胺与代乙酰胺的不同亚芳基反应生成 4-imino-5-thioxo-3-(pyrroline & pyrrolidine)carbonitrile 或吡咯并 [3,2-d] 噻唑。乙内酰丙二腈代乙酰胺的亚芳基的相互作用提供了相同的 5-噻喃[2,3-d]-咪唑-6-腈。此外,乙内酰氯乙酸苯胺邻氨基苯甲酸反应分别生成噻吩并[2,3-d]-咪唑-2-酮和咪唑并[4,5-b]喹啉-2,9-二酮。
  • New imidazolidineiminothione derivatives: Synthesis, spectral characterization and evaluation of antitumor, antiviral, antibacterial and antifungal activities
    作者:Ziad Moussa、Marwa A.M.Sh. El-Sharief、Samir Y. Abbas
    DOI:10.1016/j.ejmech.2016.06.051
    日期:2016.10
    data. Evaluation of antitumor, antiviral, antibacterial and antifungal activities for the synthesized compounds were carried out to probe their activities. Most of the synthesized compounds displayed antitumor activity. The presence of 3,5-dichlorophenyl moiety at N-(1) and trichlorophenyl moiety on N-(3) (2f) resulted the highest cytotoxic activity. The presence of 9H-fluorenyl moiety on N-(3) resulted
    通过使N-芳基代甲酰胺与芳基异氰酸酯生物反应,合成了一系列在N-(1)和N-(3)具有各种卤代和烷基化芳族取代基的新的咪唑烷亚基亚基衍生物。基于光谱IR,1 H NMR,13 C NMR,1 H,1 H-COSY,HSQC,19建立了咪唑烷亚酮衍生物的结构。F NMR,MS和元素分析数据。评估合成化合物的抗肿瘤,抗病毒,抗菌和抗真菌活性,以探测其活性。大多数合成的化合物显示出抗肿瘤活性。N-(1)上3,5-二氯苯基部分和N-(3)(2f)上三氯苯基部分的存在导致最高的细胞毒活性。N-(3)上9 H-基部分的存在导致最低的细胞毒活性。抗病毒筛选显示2d和2f对一种或两种病毒株具有显着活性。化合物2d(N-(1)处的3,5-二氯苯基部分和N-(3)处的4-氯苯基部分)对HAV表现出100%的抗病毒作用。化合物2f对HSV1表现出96.7%的抗病毒作用,对HAV表现出80.3
  • Imidazoline-4-thiones from cyanothioformamides and aldehyde imines: Formation, aromatization, and acetylation
    作者:Ahmed M. Sh. El-Sharief、Roger Ketcham、Monika Ries、Ernst Schaumann、Gunadi Adiwidjaja
    DOI:10.1002/jhet.333
    日期:——
    with a second equivalent of 3a to give 8 which in turn is oxidized to disulfide 9. Using araldimines 5b,5c, only 1:2 intermediates 10 derived from 3a, 3b and two moles of the imine 5 are formed, but proved to be easily oxidized to disulfides 11. Acetylation of 6 occurs chemoselectively on the exocyclic nitrogen and finally also on the thione sulfur to give 14 via 13. J. Heterocyclic Chem., (2010).
    的反应ñ -甲基- (图3a)或ñ -phenylcyanothioformamide(图3b )与acetaldimine(5A,1-基-1-乙醇),得到5-(基)咪唑烷-4-酮6B。产物6a与第二当量3a反应以得到8,其又被氧化成二硫化物9。使用阿勒二胺5b,5c,仅形成了1:2的衍生自3a,3b的中间体10和两摩尔的亚胺5,但事实证明它们易于氧化为二硫化物。11。6的乙酰化在环外氮上发生化学选择性,最后在上也发生化学反应,从而通过13生成14 。J.杂环化​​学。(2010)。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫